Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

5 big earnings reports: Rivian, Novavax plunge on wide misses | Pro Recap

Published 03/01/2023, 07:24 PM
Updated 03/01/2023, 07:24 PM
© Reuters

© Reuters

By Davit Kirakosyan

Investing.com -- Here is your daily Pro Recap of the biggest earnings headlines you may have missed on InvestingPro since yesterday’s close. Start your free 7-day trial to get this news first.

Rivian Automotive shares plunge on big Q4 revenue miss

Rivian Automotive (NASDAQ:RIVN) shares dropped more than 8% pre-market today after the company posted significantly worse than expected Q4 revenues of $663 million (vs. consensus of $729M) as it delivered only 8,054 vehicles from 10,020 produced.

Adjusted EPS came in at ($1.73), compared to the consensus of ($1.96).

The company’s production forecast for 2023 fell below analysts' expectations, with an anticipated production of 50,000 vehicles and an adjusted EBITDA of ($4.3B) for the full year.

Novavax shares plummet on Q4 miss and announced 'going concern' qualification

Novavax (NASDAQ:NVAX) shares plunged more than 24% pre-market today after the company reported a Q4 miss and announced a "going concern" qualification.

EPS came in at ($2.28), worse than the consensus of ($1.19). Revenue was $357M, missing the consensus estimate of $383.14M.

The company said it aims to reduce spending and operate efficiently to maximize opportunities and mitigate uncertainties in the COVID-19 market, but noted there is substantial doubt about its ability to continue as a going concern for one year due to revenue and funding uncertainties.

HP reports mixed Q1 results, shares rise

HP (NYSE:HPQ) rose more than 3% pre-market today following mixed Q1 earnings results. EPS came in at 0.75, better than the consensus of $0.74, while revenue of $13.8B missed the consensus estimate of $14.15B due to a weaker demand backdrop for personal computing and printer demand.

The company expects Q2/23 EPS in the range of $0.73-$0.83, compared to the consensus of $0.75. For the full year, EPS is expected in a range of $3.20-$3.60, compared with consensus estimates of $3.29.

Puma posts record 2022 revenues but sees 2023 profit falling, hikes dividend

Puma (ETR:PUMG) (OTC:PMMAF) reported record results in 2022, with a 19% rise in sales to €8.47B (€1 = $1.0642), a 15% rise in EBIT to €641M, and a 14% rise in EPS to €2.36.

Despite the strong performance last year due to factors such as the soccer World Cup and weak euro, Puma expects profits to be affected by currency movements, high freight rates, and raw materials prices.

It provided a wide forecast range of €590M-€670M for EBIT this year, with revenue growth expected to slow to just under 10%.

Furthermore, the company hiked its dividend by 14% to $0.82 a share, at the top end of its targeted payout range of 25%-35% of net earnings.

Shares were down more than 3% intra-day today in Frankfurt.

First Solar rises on Q4 beat & better-than-expected guidance

First Solar Inc (NASDAQ:FSLR) shares rose more than 4% pre-market today following better-than-expected Q4 earnings and 2023 guidance announcement.

EPS came in at ($0.07), compared to the consensus estimate of ($0.17). Revenue was $1B, in line with expectations.

For the full 2023 year, the company expects revenue in the range of $3.4-$3.6B, compared to the consensus of $3.34B, and EPS in a range of $7-$8, compared to the consensus estimate of $4.77.

InvestingPro | Be The First To Know

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.